The following is a summary of “Long-term effectiveness of aripiprazole once monthly on functioning and quality of life in schizophrenia: results of year 2 of the ReLiAM study,” published in the ...

Get detailed information on Aripiprazole, including pronunciation ... For further clarification, consult your healthcare provider. This medication is an atypical antipsychotic and antidepressant ...

The use and ethics of antipsychotic drugs in nursing homes is an ongoing discussion. Learn why these medications are ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Aripiprazole is a second-generation antipsychotic that is used to treat manic and mixed episodes associated with bipolar disorder. Like lurasidone, it can be used alone or with other medications. You ...

On March 13, 2020, the Ontario Superior Court of Justice certified a national class action on behalf of ABILIFY® and ABILIFY MAINTENA® Class Members relating to the Defendant drug manufacturers' ...

A drug-device combination, Abilify MyCite was approved by the US regulator for schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder, and as an add-on ...

We tested the hypothesis that the combination of aripiprazole and clozapine would lead to an improvement in this patient group. Methods: Eleven patients with treatment-resistant schizophrenia ...

Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine, quetiapine extended release and aripiprazole have clearly demonstrated efficacy in the treatment of MDD patients ...

Alcohol can change how your body breaks down and absorbs medications, causing adverse reactions, and even overdose. Here are ...

12 Poster Presentations Showcase Research in Schizophrenia, Bipolar I Disorder and Narcolepsy – – Results Presented From Real-World Retrospective Study of Healthcare Resource Utilization and Treatment ...

Using drugs changes a person's brain structure and functioning, particularly in areas involved in reward, stress, and self-control. These alterations make it harder for people to stop using substances ...